Rovi is mentioned in passing among Ibex 35 stocks in a weekly review of the Spanish stock market's performance.
In passing
September 2026 · 53seconds
Rovi — September 2026
15 analyses
This is a static sample. The live demo updates minute by minute, and Rovi alerts arrive by email in real time as soon as each analysis is ready.
See the live demoRequest early accessThe pharmaceutical company appears among the Ibex-35 stocks with the biggest drop at the weekly market close.
In passingVia Europa Press
The pharmaceutical company appears among the worst-performing stocks in the weekly close of the Ibex 35 index.
In passingVia Europa Press
The pharmaceutical company appears among the stocks with the biggest declines in the weekly closing of the Spanish stock market.
In passingUnfavourableVia Europa Press
The pharmaceutical company is listed among the worst-performing Ibex 35 stocks in the weekly market close.
In passingUnfavourableVia Europa Press
The pharmaceutical company is among the few Ibex 35 stocks with no sell recommendations, though analyst coverage is split evenly between buy and neutral.
Secondary
Rovi is mentioned among the Ibex 35 stocks in a market roundup of a session marked by the index's rise and geopolitical tension between the US and Iran.
In passing
Rovi is mentioned among the Ibex-35 companies in which asset manager BlackRock holds a significant shareholding.
In passing
The pharmaceutical company appears among the worst-performing stocks on a trading day when the Spanish index rose overall.
In passingUnfavourable
The pharmaceutical company appears among the biggest decliners in the daily Ibex 35 stock market session.
In passingVia Europa Press
The pharmaceutical company is listed among the worst-performing stocks of the day on the Spanish benchmark index.
In passingUnfavourableVia Europa Press
The pharmaceutical company is listed among the biggest decliners of the day on Spain's benchmark stock index.
In passingUnfavourableVia Europa Press
Rovi is mentioned only as a market capitalization reference in a comparison among Ibex 35 companies.
In passing
The company is mentioned tangentially as a comparative reference within a stock market analysis focused on another firm.
In passing
The pharmaceutical company is listed as one of the client companies of a distributed solar energy provider.
In passing
This is a static sample. The live demo updates minute by minute, and Rovi alerts arrive by email in real time as soon as each analysis is ready.
See the live demoRequest early accessAnalyses are 53seconds' own wording based on its measurements; no press content is reproduced. Data covers the last 30 days, updated 06-09-2026.